Expert Panel: Can We Delay Aging?

Nov 18

Expert Panel: Can We Delay Aging? View MoreBACK

On the heels of a study in Health Affairs, which found that research on aging can delay aging and age-related disease better than disease-specific research, while also saving the nation money, and Google’s recent announcement of its “Calico” initiative, American Federation for Aging Research (AFAR) and Science Writers in New York (SWINY)  hosted an engaging panel dialogue exploring how we can delay aging.

Panelists included two of the world’s leading researchers on the biology of aging, who discussed their research and address the question of whether such research can delay the aging process --- keeping us all healthier longer. A leading geriatrician also discussed ways that aging research is already making a difference in how we care for our aging population. 

Forty-two leading science journalists attended, including staff writers and producers from leading outlets, including Reuters, The New Yorker, 60 Minutes, Health magazine, More magazine, Remedy Health and The Scientist. Also in attendance were freelance writers who frequently contribute to such major media as TIME, Scientific American, Psychology Today, Woman¹s Day, O-The Oprah Magazine, Washington Post and, as well as major medical publications and sites.

Monday, November 18, 2013, 6-8pm
The Cornell Club
6 E. 44 St. (bet. Madison & Fifth), NYC

6-6:30  Wine, hors d’oeuvres and refreshments
6:30-8  Presentations, Q &A and panel discussion

The evening's speakers included:


Nir Barzilai, MD
Albert Einstein College of Medicine

Dr. Barzilai’s research focuses on key mechanisms in the biology of aging including the role of nutrients in extending life and the genetic determinants of lifespan. A number of his discoveries are now – or will soon be – in clinical trials.


Ana Maria Cuervo, MD, PhD
Albert Einstein College of Medicine

Dr. Cuervo is a leader in the study of protein degradation as it relates to the biology of aging, with an emphasis on neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s. 


Caroline S. Blaum, MD, MS
NYU School of Medicine
Deputy Medical Officer, AFAR

One of the nation’s leading geriatricians and researchers on the care of the aged, Dr. Blaum joined NYU last year from the University of Michigan to start the NYU Division of Geriatrics.  Her research focuses on models of care, patients with complex health histories, frailty and diabetes in older adults.


moderated by:

Kevin Lee, PhD
Executive Director, Ellison Medical Foundation

A biologist, Dr. Lee has more than 20 years of research experience in molecular genetics and neurobiology in biotechnology and academic research settings.  Most recently, as Executive Vice President - Research, Dr. Lee was responsible for the start-up and development of a New York City-based biotechnology company, Sentigen Biosciences, leading to its acquisition by Invitrogen Corporation.


Read Elsevier Connect's recap of the event here.